Neurofibromatosis Type 1 (NF1) is a genetic disorder characterized by the development of multiple benign tumors called neurofibromas, alongside skin changes and other neurological issues. The condition affects approximately 1 in 3,000 individuals worldwide, highlighting the need for effective therapeutic options. The Neurofibromatosis Type 1 Drugs Market is evolving rapidly, driven by...